Focus on Women’s Mental Health

Page 3

Recently published articles about Focus on Women’s Mental Health

JCP
Cardiac Malformation Risks After First Trimester Methylphenidate Use
Brief Report

May 15, 2023

This meta-analysis found that use of methylphenidate in the first trimester may be a risk factor for fetal congenital heart defects.
, , , et al
JCP
Pregnancy-Specific Anxiety Tool: Development and Psychometric Evaluation
Original Research

image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ April 19, 2023

The Pregnancy-Specific Anxiety Tool contributes new dimensions to the measurement of anxiety in pregnancy. Patients scoring higher than 10 on the PSAT require further assessment.
, , , et al
PCC
Management of Psychiatric Conditions in POTS
Narrative Review

January 31, 2023

This review provides an evidence-based approach to treating common psychiatric conditions in those who suffer from POTS, with a particular emphasis on side effects that may worsen the associated...
, , , et al
JCP
Effect of Zuranolone on Anxiety and Insomnia in Postpartum Depression
Original Research

January 30, 2023

Zuranolone was associated with improvements in depressive and anxiety symptoms and was beneficial for insomnia and patient-perceived functional health in patients with PPD.
, , , et al
JCP
Peer-Delivered CBT Workshops for Postpartum Depression
Brief Report

January 2, 2023

Peer-delivered online 1-day CBT-based workshops for postpartum depression reduced depression and anxiety and improved social support and mother-infant bonding.
, , , et al
JCP
Video Intervention to Reduce Stigma: Gender Effects
Original Research

December 19, 2022

A video to reduce stigma against schizophrenia was more effective in women if the female narrator specifically referred to her gender than if she did not.
, , , et al
JCP
Developing Mental Illness Stigma–Reducing Interventions
Commentary

December 19, 2022

Research on antistigma interventions needs to look at sustained changes in attitudes and knowledge over time.
JCP
Pregnancy Outcomes After SGA Exposure: Extracting More From the Data
Letter to the Editor

November 30, 2022

Malathi Perugula, MD, and colleagues call attention to design aspects of a recent study on antipsychotic use in pregnancy.
, , , et al
JCP
Reply to Perugula et al: Toward Improving Reliability of Safety Information on Drug Exposure in Pregnancy
Letter to the Editor

November 30, 2022

Naho Yakuwa, BPharm, responds to Perugula and colleagues about a recent study on SGA use during early pregnancy.
JCP
Bipolar Disorder and PMDD: Comorbidity Conundrum
Commentary

October 26, 2022

Teri Pearlstein, MD, discusses a recent review that highlights the difficulties of diagnosing PMDD in women with bipolar disorder.
JCP
Relationship of PMDD and Bipolar Disorder
Systematic Review

October 26, 2022

In the 5 studies reviewed, 10%–15% of people with PMDD also had bipolar disorder, while 27%–76% of those with bipolar disorder also had PMDD.
, ,
JCP
Living in a Pharmacologically Imperfect World
Editorial

October 12, 2022

Joseph F. Goldberg, MD, comments on prescription of valproate in women of reproductive potential, and the risk-benefit analysis involved with choosing the least imperfect treatment option.

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe